A Critical Perspective from a Blue Ribbon Study of California's Stem Cell Awards Process
"Important" that CIRM board members not serve on grant review group, says the study
About a decade ago, the California stem cell agency paid the National Academy of Medicine (NAM) $700,000 for a study of the agency itself with the expectation that the report would generate a golden stamp of approval. It did not.
Over the years, many of the study’s recommendations were ignored. One major objection by some agency directors was that some…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.